James Mulhearn

Springhouse

Papers

1

Total Citations

26

H-Index

1

About

James Mulhearn is a leading figure in medicinal chemistry and synthetic methodology, whose work is redefining how drug discovery teams build complex molecules. His research centers on developing practical, high-throughput cross-coupling reactions that unlock new chemical space for pharmaceutical development. Mulhearn’s most impactful contribution is his pioneering work on deoxygenative C(sp²)–C(sp³) cross-coupling, a transformative method that allows chemists to directly couple abundant, inexpensive alcohols with aryl bromides. This breakthrough, detailed in his highly cited 2023 paper (26 citations), overcomes a long-standing limitation in parallel medicinal chemistry by converting alcohols—the most diverse and readily available building blocks—into valuable alkyl precursors. By automating this metallaphotoredox process, Mulhearn has equipped medicinal chemists with a powerful tool to rapidly generate libraries of drug-like compounds, dramatically accelerating the hit-to-lead optimization cycle. His work stands as a landmark achievement in synthetic methodology, bridging the gap between academic reaction development and industrial-scale drug discovery, and establishing him as a key innovator in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Enabling Deoxygenative C(sp<sup>2</sup>)-C(sp<sup>3</sup>) Cross-Coupling for Parallel Medicinal Chemistry
26 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Springhouse

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago